(NASDAQ: DXCM) Dexcom's forecast annual revenue growth rate of 13.46% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.27%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Dexcom's revenue in 2025 is $4,148,000,000.On average, 9 Wall Street analysts forecast DXCM's revenue for 2025 to be $1,807,994,747,563, with the lowest DXCM revenue forecast at $1,798,165,788,836, and the highest DXCM revenue forecast at $1,818,516,168,138. On average, 9 Wall Street analysts forecast DXCM's revenue for 2026 to be $2,089,918,864,460, with the lowest DXCM revenue forecast at $2,068,719,964,526, and the highest DXCM revenue forecast at $2,138,436,678,204.
In 2027, DXCM is forecast to generate $2,376,541,605,541 in revenue, with the lowest revenue forecast at $2,261,217,299,992 and the highest revenue forecast at $2,427,968,856,942.